Demand for Anesthesia CO2 Absorbent and Impact of COVID-19……..
Global Anesthesia
CO2 Absorbent Market is expected
to reach USD 79.1 million by 2022,
according to a new report by Grand View Research, Inc. Rising geriatric
population, increasing usage of regional anesthesia, and augmenting volume of
surgical procedures across the globe are vital impact rendering drivers for the
market.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover, there
is an urgent need for a rapid acceleration in the manufacturing process for a
wide range of test-kits (antibody tests, self-administered, and others). The
report will account for Covid19 as a key market contributor.
Anesthesia CO2 absorbent forms a niche
segment within the anesthesia disposables, the demand for which is expected to
rise with increasing number of surgeries. According to the statistics provided
by the WHO in collaboration with the Department of Health Policy and Management
of Harvard, the global surgical volume is high and accounts for about 234
million surgeries per year.
Furthermore, with this increase, a
proportional rise in complications and deaths after surgery are being
witnessed. According to the statistics provided by the U.S. Agency for
Healthcare Research and Quality, one in 150 patients dies due to improper
administration of anesthesia.
The Harvard School of Public Health’s
study links economic conditions of a country with volume of surgeries and
states that prevalence of major surgeries is 37 times higher in countries with
healthcare expenditure above USD 1,000 per person.
To Request Sample Copy of this report, click the link:
Further key findings from the study
suggest:
·
Amsorb is expected to witness
the fastest growth over the forecast period owing to increasing demand for
absorbents free from presence of KOH and clarity in exhaustion indication.
Amsorb is anticipated to grow at a CAGR of over 10.0% over the next seven years
and contribute about 14.0% revenue to the industry.
·
Latin America and Asia Pacific
are predicted to be the fastest growing regions for the anesthesia CO2 absorbent
market. Together, they are expected to hold over 25.0% of the market share by
2022. Strategic reforms in healthcare policies and increasing healthcare
spending patterns are expected to be the market drivers within the region.
·
Key players of the industry
include GE Healthcare, Smiths Medical, CareFusion (Becton Dickinson and Co.),
Armstrong Medical, and Drager Medical GmbH. Other players include King
Pharmaceuticals, Allied Healthcare Products, Molecular Products, Micropore, and
Medisize. GE Healthcare’s vital sign division responsible for manufacturing of
anesthesia CO2 absorbent was acquired by CareFusion in 2013,
thereby making it a leader for single patient use consumables for
anesthesiology.
·
Also, cases of patent
infringement are being reported by players such as Drager. In October 2015, the
company filed a patent infringement lawsuit against Allied Healthcare alleging
infringement carbolyme single use carbon dioxide absorption cartridges. This action
is anticipated to help the company maintain its market share and control
competition.
The
global Anesthesia CO2 Absorbent Market size was valued at USD 43.7 million in
2015 and is expected to grow at a CAGR of 8.8% over the next seven years. Some
key drivers includethe rising incidences of chronic illnesses and fatal
accidents, augmentinggeriatric population, and increasing volume of surgeries.
Increasing
incidences of chronic conditionsare expected to increase demand for surgeries.
With rising volume of surgeries, required anesthesia is anticipated to rise,
thereby propelling market growth. Furthermore, guidelines and safety parameters
decided by institutes such as the Anesthesia Patient Safety Foundation, the
CEA, and the CDC are other vital impact rendering drivers.
A
huge geriatric population base is prone to suffer from diseases such as cardiac
disorders, neurological conditions, respiratory diseases, and diabetes,
ultimately demanding surgical intervention. This acts as a major driver for
growth.
According
to the WHO, about 7.6% of the population suffers from respiratory diseases
globally.Prevalence of respiratory diseases increases with age and would
affectover 15.0% for geriatric population.
Supportive
government initiatives for healthcare are expected to positively impact growth
of anesthesia disposables and thereby the anesthesia CO2 absorbent market.For
instance, it intends to expand its infrastructure to grassroots medical
networks through investments in hospitals.
In
February 2015, the European Investment Bank announced a grant of USD 150.9
million for construction of the Midland Metropolitan Hospital in England. This
hospital is expected to specialize in accident and trauma casesand form the
largest emergency department of the country.
Have any Query? Ask our Experts:
Grand View Research has segmented the
global Anesthesia CO2 Absorbent Market on the basis of products:
Global Anesthesia CO2 Absorbent Product
Outlook (Revenue, USD Million, 2012 - 2022)
·
Soda lime
·
Medisorb
·
Dragersorb
·
Amsorb
·
Litholyme
·
Others
The
key products analyzed in the study are Soda lime, Medisorb, Dragersorb, Amsorb,
Litholyme, and others.The brands, Medisorb, Dragersorb, and Amsorb are
currently capturing majority of the market share. However, over the next seven
years, newer formulations such as SpiraLith are anticipated to change the
dynamics.
Medisorb
is expected to dominate the market in 2015 with over 25% share owing to the
company’s efficient distribution network and goodwill. Amsorb plus from the
Amsorb segment is the latest product offered by the manufacturer and is
documented to eliminate formation of toxic products such as compound A and
carbon monoxide. Hence, it is expected to witness the fastest growth over the
forecast period.
Continuous
evolution of absorbent formulations to enhance product performance is expected
to propel demand over the next seven years. Manufacturers are primarily
focusing on preventing the formation of fatal compounds and increasing the
absorption capacity during the anesthesia process.
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.

Comments
Post a Comment